Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Reirradiation human spinal cord tolerance for stereotactic body radiotherapy.

Sahgal A, Ma L, Weinberg V, Gibbs IC, Chao S, Chang UK, Werner-Wasik M, Angelov L, Chang EL, Sohn MJ, Soltys SG, L├ętourneau D, Ryu S, Gerszten PC, Fowler J, Wong CS, Larson DA.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):107-16. doi: 10.1016/j.ijrobp.2010.08.021. Epub 2010 Oct 15.

PMID:
20951503
2.

Proposal of human spinal cord reirradiation dose based on collection of data from 40 patients.

Nieder C, Grosu AL, Andratschke NH, Molls M.

Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):851-5. Review.

PMID:
15708265
3.

Update of human spinal cord reirradiation tolerance based on additional data from 38 patients.

Nieder C, Grosu AL, Andratschke NH, Molls M.

Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1446-9. Epub 2006 Nov 2. Review.

PMID:
17084560
4.

Radiation dose-volume effects in the spinal cord.

Kirkpatrick JP, van der Kogel AJ, Schultheiss TE.

Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S42-9. doi: 10.1016/j.ijrobp.2009.04.095. Review.

PMID:
20171517
5.

Reirradiation tolerance of the human brain.

Mayer R, Sminia P.

Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1350-60. Epub 2007 Nov 26. Review.

PMID:
18037587
6.

Stereotactic body radiotherapy is an effective treatment in reirradiating spinal metastases: current status and practical considerations for safe practice.

Masucci GL, Yu E, Ma L, Chang EL, Letourneau D, Lo S, Leung E, Chao S, Hyde D, Gorgulho A, Muacevic A, Larson DA, Fehlings MG, Sahgal A.

Expert Rev Anticancer Ther. 2011 Dec;11(12):1923-33. doi: 10.1586/era.11.169. Review.

PMID:
22117159
7.

Basic principles of radiobiology, radiotherapy, and radiosurgery.

Shrieve DC, Klish M, Wendland MM, Watson GA.

Neurosurg Clin N Am. 2004 Oct;15(4):467-79, x. Review.

PMID:
15450882
8.

How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?

Teo PM, Kwan WH, Chan AT, Lee WY, King WW, Mok CO.

Int J Radiat Oncol Biol Phys. 1998 Mar 1;40(4):897-913. Review.

PMID:
9531376
9.

Alternative models for estimating the radiotherapy retreatment dose for the spinal cord.

Jones B, Hopewell JW.

Int J Radiat Biol. 2014 Sep;90(9):731-41. doi: 10.3109/09553002.2014.925151. Epub 2014 Jul 7. Review.

PMID:
24894515
10.

Stereotactic body radiotherapy for spinal and bone metastases.

Bhattacharya IS, Hoskin PJ.

Clin Oncol (R Coll Radiol). 2015 May;27(5):298-306. doi: 10.1016/j.clon.2015.01.030. Epub 2015 Feb 14. Review.

PMID:
25687175
11.

The role of stereotactic body radiotherapy and stereotactic radiosurgery in the re-irradiation of metastatic spinal tumors.

Jain AK, Yamada YJ.

Expert Rev Anticancer Ther. 2014 Oct;14(10):1141-52. doi: 10.1586/14737140.2014.940326. Epub 2014 Jul 28. Review.

PMID:
25066490
12.

Stereotactic body radiation for the spine: a review.

Chawla S, Schell MC, Milano MT.

Am J Clin Oncol. 2013 Dec;36(6):630-6. doi: 10.1097/COC.0b013e31822dfd71. Review.

PMID:
22134513
13.

Estimated Risk Level of Unified Stereotactic Body Radiation Therapy Dose Tolerance Limits for Spinal Cord.

Grimm J, Sahgal A, Soltys SG, Luxton G, Patel A, Herbert S, Xue J, Ma L, Yorke E, Adler JR, Gibbs IC.

Semin Radiat Oncol. 2016 Apr;26(2):165-71. doi: 10.1016/j.semradonc.2015.11.010. Epub 2016 Jan 4. Review.

14.

Vertebral compression fracture after stereotactic body radiotherapy for spinal metastases.

Sahgal A, Whyne CM, Ma L, Larson DA, Fehlings MG.

Lancet Oncol. 2013 Jul;14(8):e310-20. doi: 10.1016/S1470-2045(13)70101-3. Review.

PMID:
23816297
15.

Stereotactic body radiotherapy: a new paradigm in the management of spinal metastases.

Husain ZA, Thibault I, Letourneau D, Ma L, Keller H, Suh J, Chiang V, Chang EL, Rampersaud RK, Perry J, Larson DA, Sahgal A.

CNS Oncol. 2013 May;2(3):259-70. doi: 10.2217/cns.13.11. Review.

PMID:
25054466
16.

Radiation response of the central nervous system.

Schultheiss TE, Kun LE, Ang KK, Stephens LC.

Int J Radiat Oncol Biol Phys. 1995 Mar 30;31(5):1093-112. Review. Erratum in: Int J Radiat Oncol Biol Phys. 1995 Jul 15;32(4):1269.

PMID:
7677836
17.

Radiation-induced vascular damage in tumors: implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS).

Park HJ, Griffin RJ, Hui S, Levitt SH, Song CW.

Radiat Res. 2012 Mar;177(3):311-27. Epub 2012 Jan 9. Review.

PMID:
22229487
18.

Stereotactic body radiotherapy for renal cell cancer and pancreatic cancer : Literature review and practice recommendations of the DEGRO Working Group on Stereotactic Radiotherapy.

Panje C, Andratschke N, Brunner TB, Niyazi M, Guckenberger M.

Strahlenther Onkol. 2016 Dec;192(12):875-885. Epub 2016 Oct 24. Review.

PMID:
27778052
19.

Spinal metastases: Is stereotactic body radiation therapy supported by evidences?

De Bari B, Alongi F, Mortellaro G, Mazzola R, Schiappacasse L, Guckenberger M.

Crit Rev Oncol Hematol. 2016 Feb;98:147-58. doi: 10.1016/j.critrevonc.2015.11.002. Epub 2015 Nov 10. Review.

PMID:
26597017
20.

International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery.

Cox BW, Spratt DE, Lovelock M, Bilsky MH, Lis E, Ryu S, Sheehan J, Gerszten PC, Chang E, Gibbs I, Soltys S, Sahgal A, Deasy J, Flickinger J, Quader M, Mindea S, Yamada Y.

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):e597-605. doi: 10.1016/j.ijrobp.2012.03.009. Epub 2012 May 19.

PMID:
22608954

Supplemental Content

Support Center